$204.29
0%
Price vs. AI Score (Last 150 days)
Data gathered: December 9
Data gathered: December 9
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | N/A | N/A |
| Sentiment | N/A | N/A |
| Webpage traffic | N/A | N/A |
| Employee Rating | N/A | N/A |
| Google Adspend | $ N/A | N/A |
| Google Trends | N/A | N/A |
| Linkedin Employees | N/A | N/A |
| Patents | N/A | N/A |
| 4chan Mentions | N/A | N/A |
| Facebook Engagement | N/A | N/A |
| Facebook followers | N/A | N/A |
| Stocktwits Mentions | N/A | N/A |
| Stocktwits Subscribers | N/A | N/A |
| Twitter Followers | N/A | N/A |
| Youtube Subscribers | N/A | N/A |
| Instagram Followers | N/A | N/A |
| News Mentions | N/A | N/A |
| Reddit Mentions | N/A | N/A |
| Business outlook | N/A | N/A |
In the news
 |
Charles River (CRL) Up 19.7% Since Last Earnings Report: Can It Continue?December 8 - Yahoo |
Investing in the Aging Population: 3 Healthcare Stocks to WatchDecember 6 - InvestorPlace |
|
 |
Here's Why You Should Retain Charles River (CRL) Stock NowDecember 4 - Yahoo |
Creightons swings to half-year profit on cost-cutting measuresDecember 3 - Alliance News |
|
Insider Sell: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)December 1 - Yahoo Entertainment |
|
 |
Earnings’ Overlooked Role in Powering This RallyDecember 1 - Barron's |
About Charles River Laboratories
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.
| Price | $204.29 |
| Target Price | Sign up |
| Market Cap | $10.4B |
| Dividend Yield | 0.024 |
| Industry | Biotechnology |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 1.02B | 225M | 790M | 87M | 180M |
| Q2 '23 | 1.05B | 234M | 815M | 97M | 196M |
| Q1 '23 | 1.03B | 652M | 378M | 103M | 200M |
| Q4 '22 | 1.23B | 246M | 986M | 187M | 316M |
| Q3 '22 | 994M | 220M | 773M | 96M | 169M |
Insider Transactions
| LaPlume Joseph W filed to sell 23,133 shares at $197.7. December 1 '23 |
| Girshick Birgit filed to buy 44,449 shares at $187.8. November 21 '23 |
| LaPlume Joseph W filed to sell 24,983 shares at $173.8. November 13 '23 |
| WALLMAN RICHARD F filed to buy 1,000 shares at $198.8. August 29 '23 |
| LaPlume Joseph W filed to sell 24,983 shares at $216.5. August 14 '23 |
Read more about Charles River Laboratories and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions, business outlook.